Neurocrine BiosciencesNBIX
那斯達克 · USD
155.64
-2.71
(-1.71%)
收盤 09/05 03:59 (UTC+8)
盤後
155.75
+0.11
(+0.07%)
09/05 03:59 (UTC+8)
Neurocrine BiosciencesNBIX
155.64
-2.71
(-1.71%)
財務數據
損益表
- 5.15
- 5.90
- 6.22
- 6.28
- 5.73
- 6.88
- 7.95
- 8.06
- 8.15
- 9.59
- 0.02
- 14.54
- 5.40
- 0.90
- -8.78
- 20.07
- 15.62
- 1.33
- 1.12
- 17.74
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 959,000 | 814,500 | 805,500 | 794,900 | 687,500 | 572,600 | 627,700 | 622,100 | 590,200 | 515,300 |
營業成本 | 23,100 | 13,800 | 17,600 | 16,000 | 10,300 | 9,200 | 9,300 | 8,000 | 9,200 | 7,500 |
營業毛利 | 935,900 | 800,700 | 787,900 | 778,900 | 677,200 | 563,400 | 618,400 | 614,100 | 581,000 | 507,800 |
營業費用 | 784,400 | 635,900 | 577,000 | 539,900 | 530,600 | 539,800 | 476,400 | 430,300 | - | 408,500 |
研發費用 | 326,700 | 296,200 | 258,200 | 250,000 | 244,300 | 263,200 | 185,600 | 195,000 | 191,100 | 159,400 |
推銷及管理費用 | 439,700 | 318,500 | 301,800 | 291,600 | 286,300 | 276,500 | 287,800 | 234,300 | 242,000 | 243,100 |
非經常性項目費用 | 1,500 | 21,200 | 17,000 | 300 | - | 100 | 3,000 | 1,000 | 2,500 | 6,000 |
其他營業費用 | 16,500 | - | - | -2,000 | - | - | - | - | - | - |
營業利益 | 153,000 | 193,400 | 210,900 | 239,000 | 145,600 | 23,600 | 142,000 | 183,800 | 145,400 | 99,300 |
其他收入及費用 | 12,400 | 56,700 | 25,800 | 22,200 | 20,600 | 21,700 | 22,500 | 23,400 | -26,900 | -65,300 |
利息費用 | 2,900 | - | - | - | - | - | - | - | - | 1,100 |
稅前純益 | 162,200 | 246,800 | 239,400 | 291,800 | 159,500 | 14,700 | 162,600 | 190,300 | 98,600 | 34,500 |
所得稅 | 17,800 | 48,900 | 85,700 | 82,300 | 52,000 | 6,800 | 59,500 | 60,500 | 33,600 | -8,900 |
稅後純益 | 144,400 | 197,900 | 153,700 | 209,500 | 107,500 | 7,900 | 103,100 | 129,800 | 65,000 | 43,400 |
基本每股稅後盈餘(元) | 1.43 | 1.97 | 1.54 | 2.11 | 1.09 | 0.08 | 1.03 | 1.28 | 0.64 | 0.43 |
稀釋每股稅後盈餘(元) | 1.39 | 1.91 | 1.48 | 2.06 | 1.05 | 0.08 | 1.00 | 1.25 | 0.62 | 0.42 |
基本平均股數(千股) | 101000.00 | 100500.00 | 99900.00 | 99400.00 | 99000.00 | 99700.00 | 100000.00 | 101100.00 | 100800.00 | 99800.00 |
稀釋平均股數(千股) | 104200.00 | 103400.00 | 103700.00 | 102500.00 | 101000.00 | 102500.00 | 102900.00 | 104300.00 | 103900.00 | 103600.00 |
還原基本每股稅後盈餘(元) | 1.43 | 1.97 | 1.54 | 2.11 | 1.09 | 0.08 | 1.03 | 1.28 | 0.64 | 0.43 |
還原稀釋每股稅後盈餘(元) | 1.39 | 1.91 | 1.48 | 2.06 | 1.05 | 0.08 | 1.00 | 1.25 | 0.62 | 0.42 |
還原基本平均股數(千股) | 101,000 | 100,500 | 99,900 | 99,400 | 99,000 | 99,700 | 100,000 | 101,100 | 100,800 | 99,800 |
還原稀釋平均股數(千股) | 104,200 | 103,400 | 103,700 | 102,500 | 101,000 | 102,500 | 102,900 | 104,300 | 103,900 | 103,600 |
EBITDA(千元) | 192,600 | 252,800 | 244,900 | 296,800 | 163,400 | 17,700 | 164,100 | 190,300 | 98,900 | 34,700 |